curasan to Expand in the U.S. and China

curasan will invest in the targeted expansion of sales and marketing activities in the U.S. and China. The company markets CERASORB® bone void filler products.

The company expects FDA clearance of its CERASORB Ortho Foam bone regeneration material by the end of 2016, to be followed by an expected launch via new sales partners in 1Q17. Its...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us